PlainRecalls
FDA Drug Moderate Class II Terminated

Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10

Reported: November 18, 2020 Initiated: October 7, 2020 #D-0076-2021

Product Description

Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10

Reason for Recall

Presence of particulate matter in solution - black and transparent particles

Details

Distribution
Nationwide USA
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10. Recalled by Baxter Healthcare Corporation.
Why was this product recalled?
Presence of particulate matter in solution - black and transparent particles
Which agency issued this recall?
This recall was issued by the FDA Drug on November 18, 2020. Severity: Moderate. Recall number: D-0076-2021.